NO992107L - FremgangsmÕte for pÕvisning av forbindelser som modulerer effekten av fett (OB) proteinet - Google Patents

FremgangsmÕte for pÕvisning av forbindelser som modulerer effekten av fett (OB) proteinet

Info

Publication number
NO992107L
NO992107L NO992107A NO992107A NO992107L NO 992107 L NO992107 L NO 992107L NO 992107 A NO992107 A NO 992107A NO 992107 A NO992107 A NO 992107A NO 992107 L NO992107 L NO 992107L
Authority
NO
Norway
Prior art keywords
cell line
protein
derived cell
compound
response element
Prior art date
Application number
NO992107A
Other languages
English (en)
Norwegian (no)
Other versions
NO992107D0 (no
Inventor
Lee James Beeley
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9622870.5A external-priority patent/GB9622870D0/en
Priority claimed from GBGB9622866.3A external-priority patent/GB9622866D0/en
Priority claimed from GBGB9622868.9A external-priority patent/GB9622868D0/en
Priority claimed from GBGB9622850.7A external-priority patent/GB9622850D0/en
Priority claimed from GBGB9622869.7A external-priority patent/GB9622869D0/en
Priority claimed from GBGB9622847.3A external-priority patent/GB9622847D0/en
Priority claimed from GBGB9622865.5A external-priority patent/GB9622865D0/en
Priority claimed from GBGB9622849.9A external-priority patent/GB9622849D0/en
Priority claimed from GBGB9622867.1A external-priority patent/GB9622867D0/en
Priority claimed from GBGB9622851.5A external-priority patent/GB9622851D0/en
Priority claimed from GBGB9622848.1A external-priority patent/GB9622848D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO992107D0 publication Critical patent/NO992107D0/no
Publication of NO992107L publication Critical patent/NO992107L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO992107A 1996-11-01 1999-04-30 FremgangsmÕte for pÕvisning av forbindelser som modulerer effekten av fett (OB) proteinet NO992107L (no)

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
GBGB9622850.7A GB9622850D0 (en) 1996-11-01 1996-11-01 Novel method
GBGB9622869.7A GB9622869D0 (en) 1996-11-01 1996-11-01 Novel method
GBGB9622847.3A GB9622847D0 (en) 1996-11-01 1996-11-01 Novel method
GBGB9622870.5A GB9622870D0 (en) 1996-11-01 1996-11-01 Novel method
GBGB9622848.1A GB9622848D0 (en) 1996-11-01 1996-11-01 Novel method
GBGB9622866.3A GB9622866D0 (en) 1996-11-01 1996-11-01 Novel method
GBGB9622851.5A GB9622851D0 (en) 1996-11-01 1996-11-01 Novel method
GBGB9622867.1A GB9622867D0 (en) 1996-11-01 1996-11-01 Novel method
GBGB9622849.9A GB9622849D0 (en) 1996-11-01 1996-11-01 Novel method
GBGB9622865.5A GB9622865D0 (en) 1996-11-01 1996-11-01 Novel method
GBGB9622868.9A GB9622868D0 (en) 1996-11-01 1996-11-01 Novel method
PCT/GB1997/002988 WO1998020158A1 (fr) 1996-11-01 1997-10-30 Procede pour la detection de composes modulant les effets de la proteine de l'obesite (ob)

Publications (2)

Publication Number Publication Date
NO992107D0 NO992107D0 (no) 1999-04-30
NO992107L true NO992107L (no) 1999-06-30

Family

ID=27581686

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992107A NO992107L (no) 1996-11-01 1999-04-30 FremgangsmÕte for pÕvisning av forbindelser som modulerer effekten av fett (OB) proteinet

Country Status (13)

Country Link
EP (1) EP0951564A1 (fr)
JP (1) JP2001503982A (fr)
KR (1) KR20000053007A (fr)
AR (1) AR010262A1 (fr)
AU (1) AU4789297A (fr)
CA (1) CA2270431A1 (fr)
CZ (1) CZ149999A3 (fr)
IL (1) IL129685A0 (fr)
NO (1) NO992107L (fr)
NZ (1) NZ335489A (fr)
PL (1) PL333187A1 (fr)
TR (1) TR199900963T2 (fr)
WO (1) WO1998020158A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1293533B1 (it) * 1997-07-14 1999-03-01 Angeletti P Ist Richerche Bio Metodo per la selezione di molecole in grado di mimare, inibire o potenziare gli effetti della interazione tra leptina e cellule che
GB9814199D0 (en) * 1998-06-30 1998-08-26 Univ Buckingham Novel method
EP1101112B1 (fr) * 1998-07-28 2004-10-06 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Induction de genes mediee par la leptine
GB9828087D0 (en) * 1998-12-18 1999-02-17 Smithkline Beecham Plc Novel method
EP1612221A3 (fr) 2000-05-22 2008-07-23 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Piège à interaction basé sur un récepteur
GB0019327D0 (en) * 2000-08-08 2000-09-27 Buchanan Baillie Hamilton Paul Slimming system
EP1812038A1 (fr) 2004-11-18 2007-08-01 VIB vzw Domaine de fibronectine iii servant d'antagonistes de recepteurs de la leptine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643748A (en) * 1994-09-14 1997-07-01 Progenitor, Inc. HU-B1.219, a novel human hematopoietin receptor
WO1996029405A2 (fr) * 1995-03-20 1996-09-26 Ligand Pharmaceuticals Incorporated MODULATEURS DU GENE ob ET PROCEDES DE CRIBLAGE A CET EFFET
US5712094A (en) * 1995-03-27 1998-01-27 Ligand Pharmaceuticals, Inc. Methods for detecting modulators of cytokine action
CA2222409A1 (fr) * 1995-05-30 1996-12-05 Smithkline Beecham P.L.C. Procede de detection de composes modulant les effets de la proteine ob
CA2252443A1 (fr) * 1996-04-22 1997-10-30 Merck & Co., Inc. Dosage de la leptine

Also Published As

Publication number Publication date
IL129685A0 (en) 2000-02-29
NZ335489A (en) 2001-01-26
TR199900963T2 (xx) 1999-08-23
KR20000053007A (ko) 2000-08-25
CZ149999A3 (cs) 1999-10-13
WO1998020158A1 (fr) 1998-05-14
AU4789297A (en) 1998-05-29
JP2001503982A (ja) 2001-03-27
PL333187A1 (en) 1999-11-22
EP0951564A1 (fr) 1999-10-27
CA2270431A1 (fr) 1998-05-14
AR010262A1 (es) 2000-06-07
NO992107D0 (no) 1999-04-30

Similar Documents

Publication Publication Date Title
Iontcheva et al. Human salivary mucin MG1 selectively forms heterotypic complexes with amylase, proline-rich proteins, statherin, and histatins
NO962991D0 (no) Zink-finger-proteinderivater og fremgangsmåter
NO166303C (no) Fremgangsmaate ved kvantitativ bestemmelse av protein c ogaktivatorpreparat til gjennomfoering av fremgangsmaaten.
DE69531345D1 (de) Rekombinant pgp3, verfahren zu dessen herstellung, und dessen verwendung in der diagnose und therapie
NO992107L (no) FremgangsmÕte for pÕvisning av forbindelser som modulerer effekten av fett (OB) proteinet
NO865015L (no) Fremgangsmaate for utvinning av chitin fra materialer hvor chitin opptrer sammen med, eller i tilknytning til, proteinsubstanser.
NO975504L (no) Fremgangsmåte for påvisning av forbindelser som modulerer virkningene av fettproteinet
Kristjansson Genetic control of two blood serum proteins in swine
ATE373083T1 (de) Methode und zusammensetzungen zur identifizierung von morphogen-analogen
DE69638341D1 (de) Anzeigeprozessorsystem für eine punktorganisierte Anzeige von Wellenformdaten
AU2172597A (en) Protein phosphatase-1 catalytic subunit interactions
DE69316388D1 (de) CRF Bindungsproteine
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
DK0788512T3 (da) Proinsulinpeptidforbindelser til detektion og behandling af Type I-diabetes
Kontani et al. Inhibitory effects of protamines on proteolytic and adhesive activities of Porphyromonas gingivalis
ATE148744T1 (de) Neue thrombininhibitorische proteine aus landblutegeln
HUP0000034A2 (hu) Eljárás az elhízási (ob) protein hatásait moduláló vegyületek kimutatására
DeLange et al. The amino acid sequence of fragment A, an enzymically active fragment of diphtheria toxin. I. The tryptic peptides from the maleylated protein.
NO20006541L (no) Fremgangsmåte for påvisning av en forbindelse som etterligner, potensierer eller inhiberer den fysiologiske effekten av leptin
FR2509139B1 (fr) Isolement de proteine microbienne d'une teneur reduite en acides nucleiques
Adams et al. 3-Hydroxyproline content of normal urine.
RU95102036A (ru) Способ определения спонтанной двигательной активности крыс
DE69836226D1 (de) Ifn rezeptor 1 bindende proteine, dafür kodierende dna und verfahren zur regulierung der zellulären antwort auf interferone
Hejgaard Purification and Properties of Three Pig Erythrocyte Carronic Anhydrases
KR960029346A (ko) 인간 면역세포에서 포스포리파제 씨를 활성화시키는 펩티드 및 그의 선별 방법

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application